[go: up one dir, main page]

KR930702519A - Novel antibodies to treat and prevent infections in animals and humans - Google Patents

Novel antibodies to treat and prevent infections in animals and humans

Info

Publication number
KR930702519A
KR930702519A KR1019930700750A KR930700750A KR930702519A KR 930702519 A KR930702519 A KR 930702519A KR 1019930700750 A KR1019930700750 A KR 1019930700750A KR 930700750 A KR930700750 A KR 930700750A KR 930702519 A KR930702519 A KR 930702519A
Authority
KR
South Korea
Prior art keywords
humans
animals
treat
novel antibodies
prevent infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1019930700750A
Other languages
Korean (ko)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR930702519A publication Critical patent/KR930702519A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1019930700750A 1990-09-11 1993-03-11 Novel antibodies to treat and prevent infections in animals and humans Abandoned KR930702519A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909019812A GB9019812D0 (en) 1990-09-11 1990-09-11 Novel antibodies for treatment and prevention of infection in animals and man
PCT/GB1991/001554 WO1992004381A1 (en) 1990-09-11 1991-09-11 Novel antibodies for treatment and prevention of infection in animals and man

Publications (1)

Publication Number Publication Date
KR930702519A true KR930702519A (en) 1993-09-09

Family

ID=10682003

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930700750A Abandoned KR930702519A (en) 1990-09-11 1993-03-11 Novel antibodies to treat and prevent infections in animals and humans

Country Status (12)

Country Link
EP (1) EP0548190A1 (en)
JP (1) JPH06501152A (en)
KR (1) KR930702519A (en)
AU (1) AU654827B2 (en)
CA (1) CA2091335A1 (en)
GB (1) GB9019812D0 (en)
IE (1) IE913177A1 (en)
MX (1) MX9101046A (en)
NZ (1) NZ239728A (en)
PT (1) PT98944B (en)
WO (1) WO1992004381A1 (en)
ZA (1) ZA917170B (en)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859205A (en) * 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
GB8928874D0 (en) * 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
US6750325B1 (en) 1989-12-21 2004-06-15 Celltech R&D Limited CD3 specific recombinant antibody
DK0539522T3 (en) * 1990-07-19 1999-08-30 Us Commerce Improved immunotherapeutic approach for the prevention or treatment of viral disease of the respiratory tract
US5994510A (en) * 1990-12-21 1999-11-30 Celltech Therapeutics Limited Recombinant antibodies specific for TNFα
DE69233750D1 (en) 1991-04-10 2009-01-02 Scripps Research Inst Libraries of heterodimeric receptors using phagemids
LU91067I2 (en) * 1991-06-14 2004-04-02 Genentech Inc Trastuzumab and its variants and immunochemical derivatives including immotoxins
WO1994004679A1 (en) * 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
US6800738B1 (en) 1991-06-14 2004-10-05 Genentech, Inc. Method for making humanized antibodies
US5824307A (en) 1991-12-23 1998-10-20 Medimmune, Inc. Human-murine chimeric antibodies against respiratory syncytial virus
US5646253A (en) * 1994-03-08 1997-07-08 Memorial Sloan-Kettering Cancer Center Recombinant human anti-LK26 antibodies
GB9207479D0 (en) * 1992-04-06 1992-05-20 Scotgen Ltd Novel antibodies for treatment and prevention of respiratory syncytial virus infection in animals and man
EP0671927B1 (en) * 1992-09-16 2003-01-15 The Scripps Research Institute Human neutralizing monoclonal antibodies to respiratory syncytial virus
US6685942B1 (en) 1993-12-10 2004-02-03 The Scripps Research Institute Human neutralizing monoclonal antibodies to respiratory syncytial virus
EP0678122B1 (en) 1993-01-12 1999-07-28 Biogen, Inc. Recombinant anti-vla4 antibody molecules
AU689489B2 (en) * 1993-07-30 1998-04-02 Oravax, Inc Monoclonal IgA antibody against respiratory syncytial virus
US5429746A (en) 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
US6310185B1 (en) * 1994-03-08 2001-10-30 Memorial Sloan Kettering Cancer Center Recombinant human anti-Lewis Y antibodies
WO1995031546A1 (en) * 1994-04-28 1995-11-23 Scotgen Biopharmaceuticals, Inc. Recombinant human anti-varicella zoster virus antibodies
PT853487E (en) * 1995-09-18 2000-11-30 Intracel Corp NEUTRALIZING MONOCLONAL ANTIBODIES FOR RESPIRATORY SYNCYCLE VIRUS
DE69724428T3 (en) 1996-06-07 2009-07-23 Poniard Pharmaceuticals, Inc., Seattle HUMANIZED ANTIBODIES BINDING TO THE SAME ANTIGEN SUCH AS ANTIBODY NR-LU-13 AND THEIR USE IN "PRETARGETING" PROCEDURE
EP0970206B1 (en) 1997-01-27 2008-07-23 Ludwig Institute For Cancer Research Lage-1 tumor associated nucleic acids
ATE530180T1 (en) 1997-04-02 2011-11-15 Brigham & Womens Hospital METHOD FOR DETERMINING THE INDIVIDUAL RISK PROFILES OF ATHEROSCLEROTIC DISEASES
US6160099A (en) * 1998-11-24 2000-12-12 Jonak; Zdenka Ludmila Anti-human αv β3 and αv β5 antibodies
HK1041009B (en) 1998-12-30 2009-05-08 Beth Israel Deaconess Medical Center, Inc. Characterization of the soc/crac calcium channel protein family
US7166573B1 (en) 1999-05-28 2007-01-23 Ludwig Institute For Cancer Research Breast, gastric and prostate cancer associated antigens and uses therefor
JP2003527826A (en) 1999-06-30 2003-09-24 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ Cancer-associated antigens and uses thereof
EP1207905B1 (en) 1999-09-03 2010-09-01 The Brigham And Women's Hospital, Inc. Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
HK1046925A1 (en) 1999-10-19 2003-01-30 Ludwig Institute For Cancer Research Mage-a12 antigenic peptides and uses thereof
HRP20020485A2 (en) * 1999-12-23 2005-10-31 Ribapharm Inc. Methods and compositions for levovirin
CA2410371C (en) 2000-06-22 2015-11-17 University Of Iowa Research Foundation Methods for enhancing antibody-induced cell lysis and treating cancer
DE10211088A1 (en) 2002-03-13 2003-09-25 Ugur Sahin Gene products differentially expressed in tumors and their use
AU2003234407B2 (en) 2002-05-09 2008-12-18 The Brigham And Women's Hospital, Inc. 1L1RL-1 as a cardiovascular disease marker and therapeutic target
DE10254601A1 (en) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Gene products differentially expressed in tumors and their use
PT1592786E (en) 2003-02-11 2012-01-19 Shire Human Genetic Therapies Diagnosis and treatment of multiple sulfatase deficiency and other using a formylglycine generating enzyme (fge)
ES2567135T3 (en) 2003-08-29 2016-04-20 The Brigham And Women's Hospital, Inc. Hydantoin derivatives as inhibitors of cell necrosis
DE10341812A1 (en) 2003-09-10 2005-04-07 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use
DE10344799A1 (en) 2003-09-26 2005-04-14 Ganymed Pharmaceuticals Ag Identification of surface-associated antigens for tumor diagnosis and therapy
DE102004023187A1 (en) 2004-05-11 2005-12-01 Ganymed Pharmaceuticals Ag Identification of surface-associated antigens for tumor diagnosis and therapy
DE102004024617A1 (en) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use
DK1809759T3 (en) 2004-10-06 2014-01-06 Brigham & Womens Hospital RELEVANCE OF LEVELED LEVELS OF SYSTEMIC INFLAMMATION MARKERS AFTER TREATMENT
DE102005013846A1 (en) 2005-03-24 2006-10-05 Ganymed Pharmaceuticals Ag Identification of surface-associated antigens for tumor diagnosis and therapy
EP1762575A1 (en) 2005-09-12 2007-03-14 Ganymed Pharmaceuticals AG Identification of tumor-associated antigens for diagnosis and therapy
EP1790664A1 (en) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
EP1795596A1 (en) 2005-12-08 2007-06-13 Ganymed Pharmaceuticals AG Composition and methods for therapy and diagnosis of cancer
DE102005059242A1 (en) 2005-12-12 2007-06-14 Johannes Gutenberg-Universität Mainz, Vertreten Durch Den Präsidenten Molecular markers for tumor diagnosis and therapy
EP2011880B1 (en) 2006-04-13 2012-10-24 Chugai Seiyaku Kabushiki Kaisha Taurine transporter gene
EP1911851A1 (en) 2006-10-12 2008-04-16 Ganymed Pharmaceuticals AG Compositions and methods for therapy and diagnosis of cancer and cancer metastasis
WO2008103845A2 (en) 2007-02-23 2008-08-28 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services. Monoclonal antibodies that neutralize anthrax toxins
JP5635260B2 (en) 2007-03-15 2014-12-03 中外製薬株式会社 Method for producing polypeptide
MX2010001319A (en) 2007-08-07 2010-06-01 Chugai Pharmaceutical Co Ltd Method of producing heterogeneous protein.
JP5337043B2 (en) 2007-10-15 2013-11-06 中外製薬株式会社 Method for producing cells producing high production of heterologous protein
EP2060583A1 (en) 2007-10-23 2009-05-20 Ganymed Pharmaceuticals AG Identification of tumor-associated markers for diagnosis and therapy
ES2548294T3 (en) * 2007-10-24 2015-10-15 Chugai Seiyaku Kabushiki Kaisha Cell for use in the production of exogenous protein, and production procedure using the cell
EP2108701A1 (en) 2008-04-10 2009-10-14 Ganymed Pharmaceuticals AG Methods involving MS4A12 and agents targeting MS4A12 for therapy, diagnosis and testing
AU2009274129B2 (en) * 2008-07-21 2016-02-25 Immunomedics Inc. Structural variants of antibodies for improved therapeutic characteristics
EP2221063A1 (en) 2009-02-20 2010-08-25 Ganymed Pharmaceuticals AG Methods and compositions for diagnosis and treatment of cancer
US9809815B2 (en) 2009-02-20 2017-11-07 Ganymed Pharmaceuticals Ag Methods and compositions for diagnosis and treatment of cancer
EP2221375A1 (en) 2009-02-20 2010-08-25 Ganymed Pharmaceuticals AG Methods and compositions for diagnosis and treatment of cancer
US8741601B2 (en) 2009-04-22 2014-06-03 Chugai Seiyaku Kabushiki Kaisha Method for producing a cell capable of high-yield production of heteroproteins
EP2249159A1 (en) 2009-04-29 2010-11-10 Ganymed Pharmaceuticals AG Identification of tumor-associated markers for diagnosis and therapy
ES2988907T3 (en) 2009-11-11 2024-11-22 Astellas Pharma Inc Claudin 6 (CLDN6)-specific antibodies
EP3202789B1 (en) 2010-04-16 2020-05-06 Biogen MA Inc. Anti-vla-4 antibodies
US20130052209A1 (en) * 2010-04-23 2013-02-28 Purdue Research Foundation Protein drug formulations and packages
KR20190000385A (en) 2010-05-04 2019-01-02 더 브리검 앤드 우먼즈 하스피털, 인크. Detection and treatment of fibrosis
EP2404936A1 (en) 2010-07-06 2012-01-11 Ganymed Pharmaceuticals AG Cancer therapy using CLDN6 target-directed antibodies in vivo
NZ724296A (en) 2011-05-13 2020-05-29 Ganymed Pharmaceuticals Ag Antibodies for treatment of cancer expressing claudin 6
US20140322723A1 (en) 2011-11-22 2014-10-30 President and Dellows of Harvard College Diabetes diagnosis through the detection of glycated proteins in urine
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
WO2014145022A1 (en) 2013-03-15 2014-09-18 President And Fellows Of Harvard College Hybrid necroptosis inhibitors
WO2015014376A1 (en) 2013-07-31 2015-02-05 Biontech Ag Diagnosis and therapy of cancer involving cancer stem cells
CA2937866A1 (en) 2014-01-24 2015-07-30 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Antibodies against f glycoprotein of hendra and nipah viruses
WO2016062323A1 (en) 2014-10-20 2016-04-28 Biontech Ag Methods and compositions for diagnosis and treatment of cancer
JO3555B1 (en) 2015-10-29 2020-07-05 Merck Sharp & Dohme An antibody that inactivates the human pneumonia virus
US10899829B2 (en) 2016-02-23 2021-01-26 Indiana University Research And Technology Corporation Emapii neutralizing antibody limits influenza A virus (IAV)-induced lung injury
EP3463482B1 (en) 2016-06-07 2021-10-06 The Brigham and Women's Hospital, Inc. Methods relating to t peripheral helper cells in autoantibody-associated conditions
US11680110B2 (en) 2017-07-31 2023-06-20 Hoffmann-La Roche Inc. Three-dimensional structure-based humanization method
EP3800999A4 (en) 2018-06-04 2022-06-01 Biogen MA Inc. Anti-vla-4 antibodies having reduced effector function

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800078A (en) * 1987-05-28 1989-01-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb

Also Published As

Publication number Publication date
EP0548190A1 (en) 1993-06-30
PT98944A (en) 1992-08-31
AU8505891A (en) 1992-03-30
ZA917170B (en) 1992-07-29
JPH06501152A (en) 1994-02-10
MX9101046A (en) 1992-05-04
NZ239728A (en) 1995-07-26
PT98944B (en) 1999-02-26
IE913177A1 (en) 1992-03-11
GB9019812D0 (en) 1990-10-24
CA2091335A1 (en) 1992-03-12
WO1992004381A1 (en) 1992-03-19
AU654827B2 (en) 1994-11-24

Similar Documents

Publication Publication Date Title
KR930702519A (en) Novel antibodies to treat and prevent infections in animals and humans
NO912799D0 (en) ANIMAL PRE-ADDITIVE IN GRANULATE.
NO921863D0 (en) ANTIBODIES AND USES THEREOF
FI104109B1 (en) large diesel
BR9102840A (en) ABSORBENT PRODUCT AND METHOD OF DOING THE SAME
BR9106438A (en) SYNERGISTIC THERAPEUTIC COMPOSITIONS AND PROCESSES
FI900708A7 (en) Human immune system in an animal
EP0730609A4 (en) RECOMBINANT IL4 ANTIBODIES USEFUL IN THE TREATMENT OF IL4 RELEASING DISEASES
MX173979B (en) TENSIONER ENCLOSED IN PULLEY AND SYSTEM
EP0021230A3 (en) An agent for preventing or treating infections in human beings and animals
ITTO910156A0 (en) COMPOUND AND METHOD TO ENHANCE HUMAN PERFORMANCE.
FI943974L (en) Treatment water for skin infections in domestic animals
FI924457A7 (en) Compositions and methods of treatment for animal pneumonia
KR940011674U (en) Cattle ornaments with hand-moving ornaments
FI941552L (en) Use of gamma-INF to treat infections in transplant recipients
BR9106742A (en) PREPARATION OF ANYTHING NIOBIO AND TANTALO PENTAFLUORIDES
FI892235A7 (en) Improvements related to the registration method and device
BR9103730A (en) TRAMPOLIN AND TRAMPOLIN MAT
FI924428A7 (en) Polypeptides useful in the diagnosis and treatment of mycoplasma infections in animals
DE69115602D1 (en) Hair treatment composition
FI952108A7 (en) Fibronectin-binding protein and its preparation
DE69117441D1 (en) Field effect transistor
KR920000051U (en) Fish and fish catching complex
FI885872A7 (en) Mixtures and methods for improving frost tolerance in animals and humans
DK22892D0 (en) IMPROVEMENT IN TREATMENT

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19930311

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19960913

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19930311

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19990127

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19990730

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee